Want to see AU:BOT full AI Analyst Report?
Total Valuation
Botanix Pharmaceuticals Limited has a market cap or net worth of AU$52.47M. The enterprise value is AU$34.48.
Market CapAU$52.47M
Enterprise ValueAU$34.48
Share Statistics
Botanix Pharmaceuticals Limited has 2,761,546,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,761,546,100
Owned by Insiders2.05%
Owned by Institutions―
Financial Efficiency
Botanix Pharmaceuticals Limited’s return on equity (ROE) is -1.10 and return on invested capital (ROIC) is -77.62%.
Return on Equity (ROE)-1.10
Return on Assets (ROA)-0.66
Return on Invested Capital (ROIC)-77.62%
Return on Capital Employed (ROCE)-0.92
Revenue Per Employee3.14M
Profits Per Employee-6.34M
Employee Count11
Asset Turnover0.33
Inventory Turnover3.00
Valuation Ratios
The current PE Ratio of Botanix Pharmaceuticals Limited is ―. Botanix Pharmaceuticals Limited’s PEG ratio is 0.02.
PE Ratio―
PS Ratio1.19
PB Ratio0.65
Price to Fair Value0.65
Price to FCF-0.64
Price to Operating Cash Flow-0.66
PEG Ratio0.02
Income Statement
In the last 12 months, Botanix Pharmaceuticals Limited had revenue of 34.51M and earned -69.77M in profits. Earnings per share was -0.03.
Revenue34.51M
Gross Profit-59.43M
Operating Income-69.31M
Pretax Income-69.77M
Net Income-69.77M
EBITDA-69.31M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -64.60M and capital expenditures 4.00, giving a free cash flow of -64.60M billion.
Operating Cash Flow-64.60M
Free Cash Flow-64.60M
Free Cash Flow per Share-0.02
Dividends & Yields
Botanix Pharmaceuticals Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.10
52-Week Price Change-88.39%
50-Day Moving Average0.02
200-Day Moving Average0.05
Relative Strength Index (RSI)46.68
Average Volume (3m)6.05M
Important Dates
Botanix Pharmaceuticals Limited upcoming earnings date is Mar 3, 2027, TBA (Confirmed).
Last Earnings DateAug 26, 2026
Next Earnings DateMar 3, 2027
Ex-Dividend Date―
Financial Position
Botanix Pharmaceuticals Limited as a current ratio of 2.59, with Debt / Equity ratio of 23.21%
Current Ratio2.59
Quick Ratio1.58
Debt to Market Cap0.35
Net Debt to EBITDA0.32
Interest Coverage Ratio-24.43
Taxes
In the past 12 months, Botanix Pharmaceuticals Limited has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Botanix Pharmaceuticals Limited EV to EBITDA ratio is -0.28, with an EV/FCF ratio of -0.30.
EV to Sales0.56
EV to EBITDA-0.28
EV to Free Cash Flow-0.30
EV to Operating Cash Flow-0.30
Balance Sheet
Botanix Pharmaceuticals Limited has AU$36.63M in cash and marketable securities with AU$14.74M in debt, giving a net cash position of AU$21.89M billion.
Cash & Marketable SecuritiesAU$36.63M
Total DebtAU$14.74M
Net CashAU$21.89M
Net Cash Per Share<AU$0.01
Tangible Book Value Per ShareAU$0.02
Margins
Gross margin is -172.20%, with operating margin of -200.82%, and net profit margin of -202.15%.
Gross Margin-172.20%
Operating Margin-200.82%
Pretax Margin-202.15%
Net Profit Margin-202.15%
EBITDA Margin-200.82%
EBIT Margin-200.82%
Analyst Forecast
The average price target for Botanix Pharmaceuticals Limited is AU$0.57, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.57
Price Target Upside2750.00% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast499.47%
EPS Growth Forecast31.20%